QIAGEN NV (QGEN)
48.57
+0.25
(+0.52%)
USD |
NYSE |
Feb 20, 16:00
48.63
+0.06
(+0.12%)
After-Hours: 20:00
QIAGEN Total Liabilities (Quarterly) : 2.518B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| InflaRx NV | 23.25M |
| CDT Equity, Inc. | 4.274M |
| LENZ Therapeutics, Inc. | 16.78M |
| Liminatus Pharma, Inc. | 2.988M |
| Oruka Therapeutics, Inc. | 22.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.296B |
| Shareholders Equity (Quarterly) | 3.778B |
| Debt to Equity Ratio | 0.4379 |
| Current Ratio | 3.896 |
| Net Debt Paydown Yield | 0.57% |